Equilibrative Nucleoside Transporters in Fetal Endothelial Dysfunction in Diabetes Mellitus and Hyperglycaemia

被引:26
|
作者
Westermeier, Francisco [1 ,2 ]
Puebla, Carlos [1 ,2 ]
Luis Vega, Jose [1 ,2 ]
Farias, Marcelo [1 ,2 ]
Escudero, Carlos [1 ,2 ,3 ]
Casanello, Paola [1 ,2 ]
Sobrevia, Luis [1 ,2 ]
机构
[1] Pontificia Univ Catolica Chile, CMPL, Dept Obstet & Gynaecol, Med Res Ctr CIM,Sch Med,Fac Med, Santiago, Chile
[2] Pontificia Univ Catolica Chile, PRL, Dept Obstet & Gynaecol, Med Res Ctr CIM,Sch Med,Fac Med, Santiago, Chile
[3] Univ Bio Bio, Fac Sci, Dept Basic Sci, Chillan, Chile
关键词
Diabetes; gestational diabetes; nucleoside; transport; human; endothelium; UMBILICAL VEIN ENDOTHELIUM; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; SENSITIVE ADENOSINE TRANSPORT; GLUT1; GLUCOSE-TRANSPORTER; SLC29A1 PROMOTER ACTIVITY; RAT CARDIAC FIBROBLASTS; GLYCATION END-PRODUCTS; CATIONIC AMINO-ACIDS;
D O I
10.2174/157016109789043900
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diabetes mellitus types 1 and 2, and gestational diabetes are characterized by abnormal D-glucose metabolism and hyperglycaemia, and induce foetal endothelial dysfunction with implications in adult life increasing the risk of vascular diseases. Synthesis of nitric oxide (NO) and uptake of L-arginine (i.e. the L-arginine/NO signalling pathway) and adenosine (a vasoactive endogenous nucleoside) by the umbilical vein endothelium is altered in pathological pregnancies, including pregnancies with pre-established diabetes mellitus or in gestational diabetes. The mechanisms underlying these alterations include differential expression of equilibrative nucleoside transporters (ENTs), amino acid transporters and NO synthases (NOS). Modulation of ENTs and NOS expression and activity in endothelium involves several signalling molecules, including protein kinase C, mitogen-activated protein kinases p42 and p44, calcium and phosphatidyl inositol 3 kinase. Elevated extracellular D-glucose and diabetes alters human endothelial function. However, information regarding modulation the transport capacity as well as expression of ENTs is limited. This review focuses on the effect of diabetes mellitus and gestational diabetes, and hyperglycaemia on the reported mechanisms described for transcriptional and post-transcriptional regulation of ENTs, and the potential consequences for foetal endothelial function in these pathologies. Recent available information regarding functional consequences of an abnormal environment on the functionality of the endothelium from microvasculature of the human placenta is mentioned. The available information is scarce, but it could contribute to a better understanding of the cell and molecular basis of the altered vascular endothelial function in this pathological conditions, emphasizing the key role of this type of epithelium in fetal-placental function and the normal foetal development and growth.
引用
收藏
页码:435 / 449
页数:15
相关论文
共 50 条
  • [1] Effect of hyperglycaemia on cellular localization of human equilibrative nucleoside transporters (hENT) in umbilical vein endothelial cells
    Aguayo, C
    Casado, J
    Pastor-Anglada, M
    Sobrevia, L
    JOURNAL OF PHYSIOLOGY-LONDON, 2001, 536 : 165P - 166P
  • [2] Sustained adenosine exposure causes endothelial mitochondrial dysfunction via equilibrative nucleoside transporters
    Ko, Junsuk
    Rounds, Sharon
    Lu, Qing
    PULMONARY CIRCULATION, 2020, 10 (02)
  • [3] Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: Implications in foetal endothelial dysfunction in human pregnancy diseases
    Casanello, Paola
    Escudero, Carlos
    Sobrevia, Luis
    CURRENT VASCULAR PHARMACOLOGY, 2007, 5 (01) : 69 - 84
  • [4] Localization of equilibrative nucleoside transporters in the rat brain
    Alanko, L
    Porkka-Heiskanen, T
    Soinila, S
    JOURNAL OF CHEMICAL NEUROANATOMY, 2006, 31 (03) : 162 - 168
  • [5] Endothelial dysfunction in diabetes: Evidence for the role of hyperglycaemia
    Rajbhandari, SM
    Dent, MT
    Plater, ME
    Harris, ND
    Tesfaye, S
    Ward, JD
    DIABETOLOGIA, 2000, 43 : A53 - A53
  • [6] Endothelial dysfunction in diabetes mellitus
    Hadi, Hadi A. R.
    Suwaidi, Jassim A. L.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (06) : 853 - 876
  • [7] Endothelial dysfunction in diabetes mellitus
    Chakir, M
    Plante, GE
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1996, 54 (01): : 45 - 51
  • [8] Endothelial dysfunction in diabetes mellitus
    Cosentino, F
    Lüscher, TF
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 : S54 - S61
  • [9] Endothelial Dysfunction in Diabetes Mellitus
    Tripolt, N.
    Sourij, H.
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2010, 3 (02): : 20 - 24
  • [10] Endothelial dysfunction in diabetes mellitus
    Schiekofer, S
    Balletshofer, B
    Andrassy, M
    Bierhaus, A
    Nawroth, PP
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (05): : 503 - 511